LongCovid
The results of a new study, published in the Lancet eClinical Medicine, showed that an experimental drug (AXA1125) significantly reduces fatigue in people with Long COVID. Scientists who carried out the small-scale clinical trial believe this drug may increase energy production in cells and reduce inflammation for people fighting the virus and its aftereffects.
A very interesting and powerful testimony of a 28-year old law student from Canada suffering Long COVID since March 2020. This article, where Sophie Harrison shares her experience with Long…
📅 08/03/2024 Celebrate International Women’s Day: Empowering Women Worldwide! As we celebrate International Women’s Day, we honour the remarkable achievements, resilience and contributions of women around the world.…
An excellent article by Carlo Cervia-Hasler et al. recently published in Science Magazin is now available. In this multicenter study, researchers monitored 113 COVID-19 patients for up to one…
New World Health Organization article. “At 12 years old, Jay should be out playing sports and enjoying school and friendships. Instead, 18 months after a bout of COVID-19 and 6…